A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA ...

The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

Scientists could soon develop personalized cancer vaccines.

Moderna has begun a large-scale clinical trial of its mRNA-based bird flu vaccine, enrolling about 4,000 adults in the U.S. and U.K. The move follows earlier promising safety and immune response data ...

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

There is some promising news for pancreatic cancer research, as medical data show lasting results from the trial of a vaccine ...

Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...

This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...

The U.S. Food and Drug Administration (FDA) is reviewing a new flu vaccine for adults age 50 and older. If approved, it would be the first influenza shot to use mRNA technology, and experts say it ...